Condition: Mitral Regurgitation · Sponsor: Sutra Medical, Inc.
Study to evaluate the feasibility, safety and performance of the Sutra Hemi-valve Transcatheter Mitral Valve Replacement System in patients with moderate-severe and severe symptomatic mitral regurgitation who are at high risk for surgical treatment.
This description comes directly from the study's public registry record.
Caitlin Martin, PhD · 949-317-3672 · cmartin@sutramedical.com
Always discuss trial participation with your own doctor first.
| Waikato Hospital | Hamilton, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06552689